Phase 3 Papulopustular Rosacea Study

Clinical trial NCT01493687 · COMPLETED

Trial details

NCT number: NCT01493687
Sponsor: Galderma R&D
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Papulopustular Rosacea (PPR)

Start date: 2011-12-01
Primary completion: 2013-07-01
Enrollment: 683

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.